February 20, 2026
In 2025, more operators are discovering an uncomfortable truth: a Certificate of Analysis (COA) can be the most “polished” document in your compliance binder—and still be wrong, manipulated, or outright counterfeit.
Retailers and distributors report familiar patterns:
At the same time, regulators are tightening testing expectations, and courts continue to support state authority to regulate intoxicating hemp-derived products (which often rely on COAs to justify legality at retail). That combination increases the risk that weak paperwork becomes not just a business nuisance, but a trigger for enforcement and a civil liability multiplier.
This article is informational only, not legal advice.
While requirements vary by state, most regulated programs converge on a few core expectations:
Examples of official regulatory references businesses routinely use:
Even where a state doesn’t explicitly mandate “digital signatures,” most do require accurate records, truthful labeling, and traceability—which means a retailer that cannot validate COAs is exposed when something goes wrong.
COA fraud rises when three forces align:
When margins are thin, the temptation grows to:
Many intoxicating hemp products are marketed nationally, but enforcement and legality are increasingly state-specific. As more states restrict certain cannabinoids, serving sizes, or total THC concepts, the COA becomes the primary defense a product brand uses to claim compliance.
If that COA is manipulated—or simply uses outdated methods—retailers can be left holding the bag.
Legitimate labs are increasingly expected to demonstrate:
Two developments matter here:
The result: a widening gap between labs that can defend results technically—and documentation that’s easy to counterfeit.
If your intake process still relies on emailed PDFs, you’re operating in an environment that assumes good faith. 2025 doesn’t.
Below are practical, field-tested counter-fraud controls that do not require rewriting your entire compliance program.
A digital signature is not the same as a typed name or an image of a signature. In practice, it means the COA PDF is cryptographically signed (often via Adobe Approved Trust List / certificate-based signing), so:
Require that COAs be issued as:
Train receiving/QC staff to:
If a vendor says “we can’t digitally sign,” treat it as a maturity signal and increase scrutiny (portal verification + raw data requests).
The easiest way to defeat PDF tampering is to stop treating the PDF as the “source of truth.”
Require that product packaging or case labels include a QR code that resolves to:
If you want a lightweight integrity control, implement hashing.
If the hash differs, the file changed. That doesn’t automatically prove fraud (labs do reissue corrected reports), but it triggers a required escalation: verify through the lab portal and request a reissued, digitally signed version.
The most effective fraud deterrent is requiring that vendors and labs can produce raw analytical data when asked.
For potency and common contaminants, ask for:
Where possible, request native instrument files (vendor-dependent) or a secure raw-data package with metadata.
Use a risk-based trigger, for example:
Counterfeiters can edit a PDF quickly. They typically cannot fabricate coherent raw data with QC and metadata that stands up to scrutiny.
Retail compliance teams rarely have time to judge analytical chemistry. But you can still use objective signals.
Include contractual requirements that the lab (or the vendor’s lab) can provide:
AOAC CASP is one place labs align around method performance expectations and competence frameworks. Resource: https://www.aoac.org/science-programs/cannabis/
Your goal is not to prescribe a method, but to prevent “black box” testing.
Minimum fields to collect:
NIST’s cannabis-related quality assurance efforts are useful here because they push labs toward traceable, comparable measurement. Start with NIST’s QA program page: https://www.nist.gov/programs-projects/cannabis-quality-assurance-program
Below is a short protocol designed for store managers, intake staff, and compliance leads. It is meant for routine use—no special equipment required.
Confirm the COA includes and matches:
Red flags:
Spot-check:
Do this calculation during intake:
Fraud tell: a label that is mathematically inconsistent with the COA (common when a PDF was edited but the rest of the report wasn’t).
Because rules differ widely, set one universal intake control:
If the COA does not list the relevant analytes, it is not fit for retail reliance.
Confirm the COA includes the required panels for the product type and matrix. At a minimum, you should ensure:
Fraud tell: “Pass” everywhere with identical fonts and alignment that look like a template, or missing units/LOQs.
Require at least one of:
If neither exists, escalate to raw data request or reject.
Create a simple intake record:
This matters because if enforcement asks “how did you vet this,” you can show a repeatable control.
Your purchase agreements and vendor onboarding docs are your strongest levers. Consider adding clauses (review with counsel):
Even if a retailer did not alter a COA, stocking product based on weak or unverifiable documentation can create layered exposure:
A defensible program is one that shows you used reasonable, repeatable controls to verify what you sold.
If you need a phased approach:
If you want help turning these controls into a repeatable SOP—aligned to your specific state rules, product categories, and inspection realities—use https://cannabisregulations.ai/ to track updates, standardize intake audits, and strengthen your cannabis compliance documentation across licensing, regulations, and dispensary rollout requirements.
In 2025, more operators are discovering an uncomfortable truth: a Certificate of Analysis (COA) can be the most “polished” document in your compliance binder—and still be wrong, manipulated, or outright counterfeit.
Retailers and distributors report familiar patterns:
At the same time, regulators are tightening testing expectations, and courts continue to support state authority to regulate intoxicating hemp-derived products (which often rely on COAs to justify legality at retail). That combination increases the risk that weak paperwork becomes not just a business nuisance, but a trigger for enforcement and a civil liability multiplier.
This article is informational only, not legal advice.
While requirements vary by state, most regulated programs converge on a few core expectations:
Examples of official regulatory references businesses routinely use:
Even where a state doesn’t explicitly mandate “digital signatures,” most do require accurate records, truthful labeling, and traceability—which means a retailer that cannot validate COAs is exposed when something goes wrong.
COA fraud rises when three forces align:
When margins are thin, the temptation grows to:
Many intoxicating hemp products are marketed nationally, but enforcement and legality are increasingly state-specific. As more states restrict certain cannabinoids, serving sizes, or total THC concepts, the COA becomes the primary defense a product brand uses to claim compliance.
If that COA is manipulated—or simply uses outdated methods—retailers can be left holding the bag.
Legitimate labs are increasingly expected to demonstrate:
Two developments matter here:
The result: a widening gap between labs that can defend results technically—and documentation that’s easy to counterfeit.
If your intake process still relies on emailed PDFs, you’re operating in an environment that assumes good faith. 2025 doesn’t.
Below are practical, field-tested counter-fraud controls that do not require rewriting your entire compliance program.
A digital signature is not the same as a typed name or an image of a signature. In practice, it means the COA PDF is cryptographically signed (often via Adobe Approved Trust List / certificate-based signing), so:
Require that COAs be issued as:
Train receiving/QC staff to:
If a vendor says “we can’t digitally sign,” treat it as a maturity signal and increase scrutiny (portal verification + raw data requests).
The easiest way to defeat PDF tampering is to stop treating the PDF as the “source of truth.”
Require that product packaging or case labels include a QR code that resolves to:
If you want a lightweight integrity control, implement hashing.
If the hash differs, the file changed. That doesn’t automatically prove fraud (labs do reissue corrected reports), but it triggers a required escalation: verify through the lab portal and request a reissued, digitally signed version.
The most effective fraud deterrent is requiring that vendors and labs can produce raw analytical data when asked.
For potency and common contaminants, ask for:
Where possible, request native instrument files (vendor-dependent) or a secure raw-data package with metadata.
Use a risk-based trigger, for example:
Counterfeiters can edit a PDF quickly. They typically cannot fabricate coherent raw data with QC and metadata that stands up to scrutiny.
Retail compliance teams rarely have time to judge analytical chemistry. But you can still use objective signals.
Include contractual requirements that the lab (or the vendor’s lab) can provide:
AOAC CASP is one place labs align around method performance expectations and competence frameworks. Resource: https://www.aoac.org/science-programs/cannabis/
Your goal is not to prescribe a method, but to prevent “black box” testing.
Minimum fields to collect:
NIST’s cannabis-related quality assurance efforts are useful here because they push labs toward traceable, comparable measurement. Start with NIST’s QA program page: https://www.nist.gov/programs-projects/cannabis-quality-assurance-program
Below is a short protocol designed for store managers, intake staff, and compliance leads. It is meant for routine use—no special equipment required.
Confirm the COA includes and matches:
Red flags:
Spot-check:
Do this calculation during intake:
Fraud tell: a label that is mathematically inconsistent with the COA (common when a PDF was edited but the rest of the report wasn’t).
Because rules differ widely, set one universal intake control:
If the COA does not list the relevant analytes, it is not fit for retail reliance.
Confirm the COA includes the required panels for the product type and matrix. At a minimum, you should ensure:
Fraud tell: “Pass” everywhere with identical fonts and alignment that look like a template, or missing units/LOQs.
Require at least one of:
If neither exists, escalate to raw data request or reject.
Create a simple intake record:
This matters because if enforcement asks “how did you vet this,” you can show a repeatable control.
Your purchase agreements and vendor onboarding docs are your strongest levers. Consider adding clauses (review with counsel):
Even if a retailer did not alter a COA, stocking product based on weak or unverifiable documentation can create layered exposure:
A defensible program is one that shows you used reasonable, repeatable controls to verify what you sold.
If you need a phased approach:
If you want help turning these controls into a repeatable SOP—aligned to your specific state rules, product categories, and inspection realities—use https://cannabisregulations.ai/ to track updates, standardize intake audits, and strengthen your cannabis compliance documentation across licensing, regulations, and dispensary rollout requirements.
